Page last updated: 2024-09-04

cariporide and Ventricular Dysfunction, Left

cariporide has been researched along with Ventricular Dysfunction, Left in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayoub, IM; Gazmuri, RJ; Radhakrishnan, J1
Anzawa, R; Feuvray, D; Nagoshi, T; Seki, S; Taniguchi, I; Yoshimura, M1
Davies, JE; Digerness, SB; Goldberg, SP; Holman, WL; Justice, RK; Katholi, CR; Killingsworth, CR; Zaragoza, C1
Grosjean, N; Le Grand, B; Létienne, R; Vié, B1
Théroux, P1
Engelhardt, S; Hein, L; Keller, U; Klämbt, K; Lohse, MJ1

Reviews

1 review(s) available for cariporide and Ventricular Dysfunction, Left

ArticleYear
Myocardial cell protection : a challenging time for action and a challenging time for clinical research.
    Circulation, 2000, Jun-27, Volume: 101, Issue:25

    Topics: Animals; Guanidines; Humans; Myocardial Infarction; Myocardium; Sodium-Hydrogen Exchangers; Sulfones; Ventricular Dysfunction, Left

2000

Other Studies

5 other study(ies) available for cariporide and Ventricular Dysfunction, Left

ArticleYear
Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Disease Models, Animal; DNA Fragmentation; Guanidines; Heart; Heart Massage; Male; Myocardial Contraction; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley; Resuscitation; Sodium-Hydrogen Exchangers; Sulfones; Ventricular Dysfunction, Left; Ventricular Fibrillation

2009
The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice.
    Cardiovascular diabetology, 2012, Apr-11, Volume: 11

    Topics: Animals; Calcium; Diabetes Mellitus, Type 2; Disease Models, Animal; Guanidines; Male; Mice; Mice, Mutant Strains; Myocardial Reperfusion Injury; Sodium-Hydrogen Exchangers; Sulfones; Ventricular Dysfunction, Left

2012
Multiple treatment approach to limit cardiac ischemia-reperfusion injury.
    The Annals of thoracic surgery, 2005, Volume: 80, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Combined Modality Therapy; Diazoxide; Disease Models, Animal; Drug Therapy, Combination; Female; Guanidines; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Recovery of Function; Reference Values; Sulfones; Swine; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left

2005
Effects of SM-20550 against myocardial infarction-induced arrhythmias, late infarct expansion, and left ventricular dysfunction.
    Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:5

    Topics: Amidines; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiotonic Agents; Dobutamine; Guanidines; Heart; Heart Rate; Indoles; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sulfones; Tachycardia, Ventricular; Ventricular Dysfunction, Left; Ventricular Remodeling

2007
Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice.
    Circulation research, 2002, Apr-19, Volume: 90, Issue:7

    Topics: Administration, Oral; Animals; Blotting, Western; Body Weight; Cardiomegaly; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Fibrosis; Gene Expression; Guanidines; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Organ Size; Receptors, Adrenergic, beta-1; RNA, Messenger; Sodium-Hydrogen Exchangers; Sulfones; Ventricular Dysfunction, Left

2002